PAVmed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PAVmed and other ETFs, options, and stocks.

About PAVM

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. 

CEO
Lishan Aklog
CEOLishan Aklog
Employees
39
Employees39
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2014
Founded2014
Employees
39
Employees39

PAVM Key Statistics

Market cap
11.67M
Market cap11.67M
Price-Earnings ratio
-0.64
Price-Earnings ratio-0.64
Dividend yield
Dividend yield
Average volume
5.69M
Average volume5.69M
High today
$14.20
High today$14.20
Low today
$9.75
Low today$9.75
Open price
$11.93
Open price$11.93
Volume
1.30M
Volume1.30M
52 Week high
$28.44
52 Week high$28.44
52 Week low
$6.00
52 Week low$6.00

Stock Snapshot

The current PAVmed(PAVM) stock price is $10.40, with a market capitalization of 11.67M. The stock trades at a price-to-earnings (P/E) ratio of -0.64.

On 2026-01-23, PAVmed(PAVM) stock moved within a range of $9.75 to $14.20. With shares now at $10.40, the stock is trading +6.7% above its intraday low and -26.8% below the session's peak.

Trading activity shows a volume of 1.3M, compared to an average daily volume of 5.69M.

The stock's 52-week range extends from a low of $6.00 to a high of $28.44.

The stock's 52-week range extends from a low of $6.00 to a high of $28.44.

PAVM News

Simply Wall St 56m
Individual investors among Lucid Diagnostics Inc.'s largest stockholders and were hit after last week's 14% price drop

Advertisement Key Insights Lucid Diagnostics' significant individual investors ownership suggests that the key decisions are influenced by shareholders from t...

Individual investors among Lucid Diagnostics Inc.'s largest stockholders and were hit after last week's 14% price drop
TipRanks 2d
Why Are PAVmed & Lucid Diagnostics Stocks Up Today?

PAVmed (PAVM) stock rocketed higher on Wednesday after the medical technology company announced a major contract for its subsidiary, Lucid Diagnostics (LUCD). T...

People also own

Based on the portfolios of people who own PAVM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.